OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
3.650
-0.230 (-5.93%)
Feb 21, 2025, 4:00 PM EST - Market closed
OmniAb Employees
OmniAb had 106 employees as of December 31, 2023. The number of employees increased by 11 or 11.58% compared to the previous year.
Employees
106
Change (1Y)
11
Growth (1Y)
11.58%
Revenue / Employee
$192,538
Profits / Employee
-$594,509
Market Cap
441.70M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 106 | 11 | 11.58% |
Dec 31, 2022 | 95 | 21 | 28.38% |
Dec 31, 2021 | 74 | 4 | 5.71% |
Dec 31, 2020 | 70 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
OABI News
- 19 days ago - OmniAb to Participate in Two Investor Conferences in March - Business Wire
- 22 days ago - Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm - PRNewsWire
- 2 months ago - OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference - Business Wire
- 3 months ago - OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights - Business Wire
- 4 months ago - OmniAb to Participate in Two Investor Conferences in November - Business Wire
- 4 months ago - OmniAb to Report Third Quarter 2024 Financial Results on November 12 - Business Wire
- 6 months ago - OmniAb to Participate in Two Investor Conferences in September - Business Wire